Skip to main content
. 2019 Mar 29;11(4):731. doi: 10.3390/nu11040731

Table 1.

Baseline characteristics of study participants.

All Study Participants (n = 200) Vitamin D (n = 100) Placebo (n = 100)
Median IQR Median IQR Median IQR p-Value
Age (years) 45 31–54 40 30–53 47 32–55 0.230
BMI (kg/m2) 26.4 24.1–29.5 26.3 24.0–29.3 26.8 24.1–29.8 0.548
Total testosterone (nmol/L) 15.8 12.3–18.9 15.8 12.3–19.4 15.8 12.3–18.3 0.443
25-hydroxyvitamin D (nmol/L) 52.5 42.0–67.5 53 43–68 52 42–64 0.847
PTH (pg/mL) 45.8 35.8–55.6 46.6 36.2–57.0 43.4 35.8–54.3 0.317
Serum calcium (mmol/L) 2.38 2.33–2.43 2.37 2.33–2.43 2.39 2.34–2.43 0.313
Serum phosphate (mmol/L) 0.90 0.78–1.04 0.92 0.78–1.06 0.88 0.78–1.01 0.910
Urine calcium (mmol/L) 2.65 1.39–3.84 2.57 1.37–3.86 2.75 1.40–3.84 0.890
Osteocalcin (ng/mL) 21.1 17.0–27.1 20.9 16.7–25.5 21.5 17.6–27.8 0.449
CTX (ng/mL) 0.37 0.27–0.50 0.40 0.27–0.50 0.35 0.27–0.50 0.994
Total body BMD (g/cm2) 1.299 1.230–1.366 1.294 1.221–1.369 1.299 1.234–1.360 0.574
Spine BMD (g/cm2) 1.230 1.108–1.326 1.233 1.106–1.334 1.213 1.110–1.315 0.657
Femoral neck BMD (g/cm2) 1.023 0.941–1.125 1.027 0.932–1.143 1.022 0.956–1.120 0.346
Total hip BMD (g/cm2) 1.076 1.001–1.168 1.073 0.993–1.184 1.076 1.002–1.156 0.629
TBS 1.368 1.313–1.463 1.357 1.313–1.521 1.382 1.351–1.445 0.743
Season 1 (%) 34.0 32 36 0.386
Season 2 (%) 37.5 34 41
Season 3 (%) 11.5 14 9
Season 4 (%) 17.0 20 14

Comparisons of baseline characteristics between men in the vitamin D and the placebo group were performed using student’s t-test and χ2-test. Season 1: January–March, season 2: April–June, season 3: July–September, season 4: October–December; IQR=interquartile range, PTH = parathyroid hormone, CTX = beta-crosslaps, BMD = bone mineral density, TBS = trabecular bone score.